Predictors of Macular Atrophy Detected by Fundus Autofluorescence in Patients With Neovascular Age-Related Macular Degeneration After Long-Term Ranibizumab Treatment.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Ophthalmic Surgery Lasers and Imaging Retina

• Publication date

  2016-03-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.3928/23258160-20160229-04PMID 26985795
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CORRELATION BETWEEN NEOVASCULAR LESION TYPE AND CLINICAL CHARACTERISTICS OF NONNEOVASCULAR FELLOW EYES IN PATIENTS WITH UNILATERAL, NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

  2015cited by this paper
• Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation.

  2015cited by this paper
• Macular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP study.

  2015cited by this paper
• Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials.

  2015cited by this paper
• Reticular drusen in eyes with high-risk characteristics for progression to late-stage age-related macular degeneration

  2015cited by this paper
• Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990–2010

  2014cited by this paper
• Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP).

  2013cited by this paper
• Grading of Age-Related Macular Degeneration: Comparison between Color Fundus Photography, Fluorescein Angiography, and Spectral Domain Optical Coherence Tomography

  2013cited by this paper
• HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration.

  2012cited by this paper
• Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex.

  2012cited by this paper
• Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration.

  2009cited by this paper
• Quantitative fluorescein angiographic analysis of choroidal neovascular membranes: validation and correlation with visual function.

  2007cited by this paper
• Ranibizumab for neovascular age-related macular degeneration.

  2006cited by this paper
• Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

  2006cited by this paper
• The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17.

  2005cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.

  2003cited by this paper
• Visual acuity and its measurement.

  2003cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

  2001cited by this paper
• The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6.

  2001cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

  1999cited by this paper

• Blue Light and Green Light Fundus Autofluorescence, Complementary to Optical Coherence Tomography, in Age-Related Macular Degeneration Evaluation

  2025cites this paper
• Subretinal hyperreflective material in regions of atrophy and fibrosis in eyes with neovascular age-related macular degeneration.

  2024cites this paper
• Detection of macular atrophy in age-related macular degeneration aided by artificial intelligence

  2023cites this paper
• Drusen morphometrics on optical coherence tomography in eyes with age-related macular degeneration and normal aging

  2023cites this paper
• Deep learning to detect macular atrophy in wet age-related macular degeneration using optical coherence tomography

  2023cites this paper
• As in Real Estate, Location Matters: Cellular Expression of Complement Varies Between Macular and Peripheral Regions of the Retina and Supporting Tissues

  2022cites this paper
• Ocular Imaging for Enhancing the Understanding, Assessment, and Management of Age-Related Macular Degeneration.

  2021cites this paper
• Fundus autofluorescence in neovascular age-related macular degeneration, a clinicopathologic correlation relevant to macular atrophy.

  2021cites this paper
• Quantitative assessment of the severity of diabetic retinopathy.

  2020cites this paper
• Fundus autofluorescence imaging.

  2020cites this paper
• Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATT.

  2019influential citation
• Anti-Vascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration: Systematic Literature Review and Expert Opinion.

  2019cites this paper
• The fate of eyes with wet AMD beyond four years of anti-VEGF therapy

  2018cites this paper
• Atrophy in Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 15.

  2018cites this paper
• RELIABILITY OF CONFOCAL WHITE-LIGHT FUNDUS IMAGING FOR MEASUREMENT OF RETINA PIGMENT EPITHELIAL ATROPHY IN AGE-RELATED MACULAR DEGENERATION

  2017cites this paper
• Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings.

  2017cites this paper
• Predictive models of long-term anatomic outcome in age-related macular degeneration treated with as-needed Ranibizumab

  2017influential citation
• Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article

  2017cites this paper
• AntieVascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration Systematic Literature Review and Expert Opinion

  year unknowninfluential citation